EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Amniotic Fluid 8-Iso-Prostaglandin F2α Reveals Intrauterine Oxidative Stress in Fetuses with Congenital Heart Disease: A Prospective Case–Control Study

Miguel Arráez iD, Marta Camprubí-Camprubí iD, María C Escobar-Diaz iD, Laura Guirado, Laura Nogué iD, Mar Bennasar iD, Narcís Masoller iD, Fàtima Crispi iD, María Dolores Gómez-Roig, Olga Gómez iD, Míriam Pérez-Cruz

Antioxidants · 06.05.2026 · 15 (5) · 586

DOI: 10.3390/antiox15050586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 06.05.2026. Verfasst von Miguel Arráez und 10 weiteren Autor:innen. Beteiligte Einrichtung: BCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, RICORS-SAMID, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in prenatal diagnosis have improved the perinatal management of congenital heart disease (CHD). However postnatal comorbidities still persist due to multifactorial causes, which limits prenatal prediction of individual outcomes. Oxidative stress (OS), particularly lipid peroxidation, has been suggested to play a role in the development and progression of CHD, with 8-iso-prostaglandin F2α (8-iso-PGF2α) serving as a biomarker of oxidative injury. This prospective case–control study aimed to evaluate OS in fetuses with isolated major CHD by comparing amniotic fluid (AF) 8-iso-PGF2α concentrations with controls. A total of 123 fetuses (83 CHD, 40 controls) were included at a tertiary CHD referral center. CHD cases were subclassified according to anatomical type and expected fetal brain perfusion under placental circulation. Controls were gestational age-matched pregnancies undergoing amniocentesis for indications unlikely to affect OS. All pregnant women underwent standardized fetal biometry, Doppler assessment, and detailed echocardiography. AF samples were obtained by amniocentesis and analyzed for free 8-iso-PGF2α using a competitive ELISA, with values normalized to creatinine. Clinical, obstetric, and Doppler characteristics were comparable between groups. CHD fetuses showed significantly higher AF 8-iso-PGF2α concentrations than controls (2849 ± 1377 vs. 2088 ± 1087 ng/mg Cr, p = < 0.001), and remained significant after adjustment for GA, smoking status, diabetes and maternal age and body mass index (BMI). No consistent differences were observed across anatomical or hemodynamic CHD subgroups. These findings provide the first intrauterine evidence of increased lipid peroxidation in fetuses with CHD as reflected by elevated amniotic fluid 8-iso-PGF2α concentrations.

Schlagwörter

Stichwörter der Autor:innen

8-iso-prostaglandin F2αF2-isoprostanesamniotic fluidcongenital heart diseasefetal biomarkerslipid peroxidationoxidative stressprenatal diagnosis

Autor:innen und Institutionen

  • BCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.
  • Spanish Network in Maternal, Neonatal, Child and Developmental Health Research, RICORS-SAMID, RD24/0013/0004, Instituto de Salud Carlos III, 28040 Madrid, Spain.
  • Neonatology Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain.
  • Cardiovascular Research Group, Sant Joan de Deu Research Institute, 08950 Barcelona, Spain.
  • Institut de Recerca Sant Joan de Déu (IRSJD), 08950 Barcelona, Spain.
  • Cardiology Department, Sant Joan de Déu Hospital, 08950 Barcelona, Spain.

ORCID-Profile: Miguel Arráez, Marta Camprubí-Camprubí, María C Escobar-Diaz, Laura Nogué, Mar Bennasar, Narcís Masoller, Fàtima Crispi, Olga Gómez

Förderung

  • Instituto de Salud Carlos III
  • RICORS-SAMID
  • European Union

Zitieren

APA

Arráez, M., Camprubí-Camprubí, M., Escobar-Diaz, M. C., Guirado, L., Nogué, L., Bennasar, M., Masoller, N., Crispi, F., Gómez-Roig, M. D., Gómez, O., & Pérez-Cruz, M. (2026). Elevated Amniotic Fluid 8-Iso-Prostaglandin F2α Reveals Intrauterine Oxidative Stress in Fetuses with Congenital Heart Disease: A Prospective Case–Control Study. Antioxidants, 15(5), 586. https://doi.org/10.3390/antiox15050586

Vancouver

Arráez M, Camprubí-Camprubí M, Escobar-Diaz MC, Guirado L, Nogué L, Bennasar M, et al. Elevated Amniotic Fluid 8-Iso-Prostaglandin F2α Reveals Intrauterine Oxidative Stress in Fetuses with Congenital Heart Disease: A Prospective Case–Control Study. Antioxidants. 2026;15(5):586. doi:10.3390/antiox15050586

BibTeX
@article{Arrez2026,
  author = {Arráez, Miguel and Camprubí-Camprubí, Marta and Escobar-Diaz, María C and Guirado, Laura and Nogué, Laura and Bennasar, Mar and Masoller, Narcís and Crispi, Fàtima and Gómez-Roig, María Dolores and Gómez, Olga and Pérez-Cruz, Míriam},
  title = {Elevated Amniotic Fluid 8-Iso-Prostaglandin F2α Reveals Intrauterine Oxidative Stress in Fetuses with Congenital Heart Disease: A Prospective Case–Control Study},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {586},
  doi = {10.3390/antiox15050586}
}
Kostenlos starten →